- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Texan to Head NIH?
9 January 2001 7:00 pm
Rumors reached a fever pitch in Washington this week that the Bush transition team had tapped a director for the National Institutes of Health, but the supposed candidate denies all. John Mendelsohn, president of the University of Texas M. D. Anderson Cancer Center in Houston, told ScienceNOW today in a statement that although "It would be an honor to be considered" for the NIH post, "no one has approached me about it" and "I love my job."
Mendelsohn, who is said to have links to the Bush family, has worked at the University of California, San Diego, and Memorial Sloan-Kettering Cancer Center in New York City. But observers noted that if offered the NIH job, he would have to mull whether he is willing to give up positions on the boards of biotech ImClone Systems and Enron, the giant Houston-based energy company, and become a politico. And one biomedical research lobbyist expressed concern that a clinical oncologist might not "resonate with" NIH's mostly basic research grantees--and might also add to NIH's already heavy slant toward cancer research.